Private Equity and the Medicare Delivery System

Private equity acquisitions in healthcare delivery nearly tripled from 2010 to 2020. In 2024 alone, there were approximately 1,069 unique private equity-backed healthcare deals in the United States. The sectors attracting PE capital include hospitals, physician staffing, nursing homes, home health and hospice, behavioral health, and dental practices. For providers who have not been acquired, PE-backed competitors are reshaping market dynamics in ways that affect staffing, contracting, and competitive positioning.

This article examines private equity from the provider’s perspective: what PE ownership means for the competitive landscape, what the quality evidence shows, and what strategic responses are available. The question is not whether PE belongs in healthcare, which is a broader debate with legitimate arguments on multiple sides, but rather what providers should understand about PE-backed competitors and how to position themselves in markets where PE capital is active.

The Provider-Side PE Landscape

#

Private equity investment concentrates in specific healthcare sectors, each with distinct dynamics.

Physician staffing represents one of the most visible PE presence points. Emergency medicine, anesthesiology, radiology, and hospitalist medicine have seen extensive PE consolidation. Staffing companies aggregate physician practices, negotiate contracts with hospitals, and manage billing and scheduling. The business model generates returns through administrative efficiency, scale-based contracting leverage, and, critics argue, billing practices that maximize revenue extraction. The 2025 FTC settlement with Welsh Carson over its investment in US Anesthesia Partners illustrates regulatory concern about PE consolidation effects on physician markets.

Home health and hospice have attracted PE capital through roll-up strategies that combine smaller agencies into regional or national platforms. The thesis is that scale creates contracting leverage with MA plans, administrative efficiency, and referral network advantages. Quality implications are contested: PE-backed hospices have reported higher profits but lower spending on direct patient care compared to nonprofit hospices. The trade-off between efficiency and care intensity is at the core of the debate.

Behavioral health consolidation accelerated as demand for mental health services exceeded supply. PE firms acquired outpatient behavioral health practices, addiction treatment programs, and psychiatric facilities. The supply-demand imbalance gave PE-backed platforms pricing power, but also raised questions about whether profit motives align with treatment protocols for vulnerable populations.

Dental service organizations represent perhaps the most active PE roll-up sector. Dental care accounted for at least 161 PE deals in 2024, the highest deal activity of any healthcare category tracked by the Private Equity Stakeholder Project. Over half of the busiest platform companies in 2024 were dental companies. For MA plans offering dental supplemental benefits, the DSO landscape shapes network options and contracting dynamics.

Nursing home and skilled nursing facility acquisitions have generated the most concerning quality evidence. PE ownership of nursing homes has been associated with higher patient mortality rates, reduced staffing, increased hospitalization rates, and more care deficiencies across multiple studies. The July 2025 bankruptcy of Genesis Healthcare, a PE-backed nursing home operator with facilities across 17 states, illustrated the financial fragility that can accompany PE ownership structures involving asset stripping and high-risk borrowing.

The Staffing Model Disruption

#

For hospitals, PE-backed physician staffing companies create specific contracting and operational challenges.

Contract terms have shifted as staffing companies consolidated. A hospital negotiating with a PE-backed emergency medicine staffing company faces a counterparty with substantial scale and sophisticated contract expertise. The staffing company’s interests, which include maximizing revenue and returns to investors, may not align with the hospital’s interests in cost containment, quality metrics, and patient experience.

Physician availability and compensation dynamics change in PE-dominated markets. PE-backed staffing companies must generate returns, which creates pressure to maximize physician productivity while controlling compensation costs. Physicians employed by these companies report concerns about autonomy, practice incentives determined by financial targets rather than clinical judgment, and the subordination of professional values to investor returns. A 2024 Physicians Foundation survey found that only 14 percent of physicians agreed that private equity funding is good for the future of healthcare.

The No Surprises Act addressed some but not all billing concerns related to PE-backed staffing companies. The law limits surprise billing for out-of-network emergency services and certain other scenarios. However, billing and coding pattern changes after PE acquisition remain a concern. Studies have documented increased charges and billing intensity at PE-acquired facilities, reflecting pressure to maximize revenue per patient encounter.

The “captive physician” concern describes situations where physicians are employed by PE-backed entities whose practice incentives are determined by financial targets rather than clinical judgment. Corporate practice of medicine laws, which exist in some states to prohibit non-physician ownership of medical practices, have been circumvented through management service organization structures that give PE firms de facto control over clinical operations while maintaining technical compliance with ownership restrictions.

Quality and Safety Evidence

#

Research on PE ownership and healthcare quality has produced concerning findings, though causation remains debated.

A 2025 study published in Annals of Internal Medicine found that PE-acquired hospitals reduced salary and staffing in emergency departments and intensive care units after acquisition. This occurred alongside increased transfers of sicker patients to other hospitals and a 13.4 percent rise in deaths occurring in the emergency department.

A 2023 study found that among hospitals acquired by PE firms, hospital-acquired conditions among Medicare beneficiaries increased by 25 percent compared to hospitals not acquired by PE. Falls, bloodstream infections, and surgical site infections all increased, despite patients at PE-acquired hospitals being younger and lower risk sociodemographically.

In nursing homes, PE acquisition has been associated with 11 percent higher patient mortality. Staffing reductions, care deficiencies, and increased hospitalization rates for conditions typically manageable with routine care suggest that cost-cutting after acquisition affects care delivery.

PE-owned physician practices have shown nearly 20 percent fewer retinal detachment repairs, a time-sensitive procedure often reimbursed below cost. This pattern suggests that PE ownership may reduce provision of services that do not generate adequate margins, regardless of clinical necessity.

The causation question is legitimate: does PE ownership cause quality deterioration, or does PE acquire facilities that already had financial and quality challenges? The evidence suggests both dynamics are present. PE firms sometimes acquire distressed assets at favorable valuations, but the post-acquisition changes in staffing, billing, and service line offerings reflect deliberate strategy rather than inherited conditions.

The Competitive Response

#

Providers who have not been acquired face strategic choices about how to compete with PE-backed entities.

Collaborative models offer scale without PE capital. Independent practice associations, clinically integrated networks, and ACOs allow independent physicians to aggregate for contracting purposes while maintaining practice ownership. These structures require governance investment and operational coordination, but they provide alternatives to selling to PE-backed platforms. High-performing ACOs have demonstrated that physician-led organizations can succeed in value-based arrangements without PE capital or the return expectations that accompany it.

The payvider counter positions provider-sponsored plans as strategic alternatives to PE market dominance. A health system that operates its own MA plan or FIDE SNP controls the contracting relationship rather than negotiating with PE-backed competitors. The payvider model requires capital, regulatory expertise, and operational capacity, but it insulates the delivery system from the market power dynamics that PE consolidation creates.

Advocacy engagement addresses the policy environment. At least 35 states now require hospitals, health systems, physician groups, and PE firms to notify state authorities of certain proposed transactions. Fifteen states regulate transactions involving both nonprofit and for-profit entities. Massachusetts enacted legislation in January 2025 providing regulators greater authority to review material change transactions, particularly those involving PE. The FTC has increased scrutiny of healthcare PE transactions, including enforcement actions against roll-up strategies that reduce competition.

Federal legislation has been proposed to address PE practices directly. The Corporate Crimes Against Health Care Act would levy criminal penalties on PE principals found to have caused patient harm. The Health Over Wealth Act would increase transparency requirements for PE-owned facilities. Whether these bills advance depends on congressional priorities and lobbying dynamics.

For independent providers evaluating their strategic options, the question is whether PE acquisition offers benefits that alternative structures cannot provide. The capital infusion, administrative support, and scale advantages that PE brings come with return expectations, operational control by financial rather than clinical leadership, and exit timelines that prioritize investor liquidity over long-term organizational development. Providers who can access capital through other means, build scale through collaborative structures, and maintain clinical governance may find that independence offers advantages that PE acquisition forecloses.

Related Reading

#

MCR-04_11 Private Equity in Medicare Delivery: Accountability, Quality, and the Care Model Question MCR-12_02 Health System Winners and Losers: Kaiser, Intermountain, UPMC, Advocate, Geisinger